A study has found that the gene mutation that puts many black people at risk for chronic kidney disease requires higher than normal levels of a protein called suPAR to trigger the onset and progression of the disease.
As part of Rush’s new community-based health initiatives, doctors at Rush are leading Chicago’s first West Side walk toward a healthier community.
The American Hospital Association named Rush University Medical Center an Equity of Care Award honoree for efforts to reduce disparities in care.
A Rush-led study shows for the first time how dying cells ensure that they will be replaced, and suggests a new approach to shrinking cancerous tumors.
Alzheimer’s disease and aging experts are conducting a national clinical study to determine if exercise may be an effective non-drug intervention for maintaining cognitive fitness.
A new drug that is the first and only disease modifying therapy for both primary progressive and relapsing forms of multiple sclerosis (MS) is giving new hope for hundreds of thousands of Americans living with the disease.
Mechanical thrombectomy, a treatment to remove a stroke-causing blood clot in the brain, is effective in some patients even when performed within six to 24 hours after a stroke, according to the results of an international research study.
Rush has partnered with tech company Tempus to expand its biorepository of tissue samples from cancer patients in order to advance cancer care.
Rush University Medical Center has begun to offer “digital medicine.” Called Proteus Discover, it’s an FDA-approved medical “device” that pairs medication with an ingestible sensor the size of a grain of sand, which works together with a wearable sensor patch and mobile app.
Rush Oak Park Hospital has launched a cardiac rehabilitation program to help people with cardiovascular disease lead healthier, more active lives.